Product Information

MICROGESTIN 21 1.5-30 TAB is a generic product labeled by Mayne Pharma, priced at $0.4097 per EA under NDC 51862087201. Its NADAC has been published 194 times since Oct 20, 2021.

FDA first approved this application on Mar 20, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MICROGESTIN 21 1.5-30 TAB

Norethindrone Acetate/Ethinyl Estradiol
$0.4097per EA

Manufacturer

Mayne Pharma

NDC

51862087201

Classification

Generic

Dosage Form

KIT

Effective Date

6/18/2025

Approval Type

Generic (ANDA)

FDA Application

ANDA202996

FDA Approved

3/20/2014

TE Code

AB

On Market Since

10/11/2020

Price Statistics

The NADAC for MICROGESTIN 21 1.5-30 TAB has been published 194 times since Oct 20, 2021, and over the history we have for it it has declined 20.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4097 per EA
All-time high$0.6344 (Jan 12, 2022)
All-time low$0.3066 (Jul 17, 2024)
Median price$0.5094
Average price$0.4830
Largest weekly change+67.3% (Aug 21, 2024)
Weeks tracked194
Tracking sinceOct 20, 2021

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-12.5%

5Y

N/A

All

-20.2%

Last surveyed Jul 2, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of MICROGESTIN 21 1.5-30 TAB?

The current National Average Drug Acquisition Cost (NADAC) for MICROGESTIN 21 1.5-30 TAB, manufactured by Mayne Pharma, is $0.4097 per EA (NDC 51862087201), effective Jul 2, 2025.

How has the price of MICROGESTIN 21 1.5-30 TAB changed over time?

Over the history we have for it, the NADAC for MICROGESTIN 21 1.5-30 TAB has declined 20.2%. It has been tracked across 194 weekly CMS publications since Oct 20, 2021.

What are the highest and lowest recorded NADAC prices for MICROGESTIN 21 1.5-30 TAB?

Since Oct 20, 2021, the NADAC for MICROGESTIN 21 1.5-30 TAB has ranged from a low of $0.3066 (Jul 17, 2024) to a high of $0.6344 (Jan 12, 2022), with a median of $0.5094 per EA.

Are there cheaper alternatives to MICROGESTIN 21 1.5-30 TAB?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MICROGESTIN 21 1-20 TABLET, is $0.1703 per EA — about 58% below MICROGESTIN 21 1.5-30 TAB.

Who manufactures MICROGESTIN 21 1.5-30 TAB?

MICROGESTIN 21 1.5-30 TAB (NDC 51862087201) is labeled by Mayne Pharma, and CMS classifies it as a generic product.